Enanta Pharmaceuticals reported $-33847000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4717M 357M
Acorda Therapeutics ACOR:US $ -16.7M 5.14M
Amgen AMGN:US $ 2500M 196M
Anika Therapeutics ANIK:US $ -3.55M 5.57M
Arrowhead Research ARWR:US $ 41.55M 104.87M
AstraZeneca AZN:LN 878M 1.17B
Biocryst Pharmaceuticals BCRX:US $ -49.96M 53.62M
Biogen BIIB:US $ 610.7M 23.6M
Bristol Myers Squibb BMY:US $ 2553M 90M
Clovis Oncology CLVS:US $ -50.36M 4.68M
Enanta Pharmaceuticals ENTA:US $ -33.85M 3.44M
Gilead Sciences GILD:US $ 197M 743M
GlaxoSmithKline GSK:LN 2.8B 1.91B
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Heron Therapeutics HRTX:US $ -62.92M 9.39M
Insmed INSM:US $ -89833000 9.24M
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
Johnson & Johnson JNJ:US $ 5862M 1026M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Ligand Pharmaceuticals LGND:US $ -7.81M 20.54M
Marinus Pharmaceuticals MRNS:US $ -16.71M 10.4M
Merk MRK:US $ 5569M 1994M
Neurocrine Biosciences NBIX:US $ 3.1M 39.4M
Novartis NOVN:VX 2.85B 290M
Novavax NVAX:US $ 209.29M 1034.26M
Pfizer PFE:US $ 9873M 5297M
Ptc Therapeutics PTCT:US $ -86.52M 1.79M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M
Vital Therapies VTL:US $ -21.44M 0.29M
YTE INCY:US $ 116.54M 5.81M